摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

6-O-acetyl-2-azido-2-deoxy-3,4-di-O-methyl-α,β-D-glucopyranose trichloroacetimidate | 150126-03-7

中文名称
——
中文别名
——
英文名称
6-O-acetyl-2-azido-2-deoxy-3,4-di-O-methyl-α,β-D-glucopyranose trichloroacetimidate
英文别名
[(2R,3S,4R,5R)-5-azido-3,4-dimethoxy-6-(2,2,2-trichloroethanimidoyl)oxyoxan-2-yl]methyl acetate
6-O-acetyl-2-azido-2-deoxy-3,4-di-O-methyl-α,β-D-glucopyranose trichloroacetimidate化学式
CAS
150126-03-7
化学式
C12H17Cl3N4O6
mdl
——
分子量
419.649
InChiKey
RZGFJNZWYHPMJA-WWGUJXLXSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.6
  • 重原子数:
    25
  • 可旋转键数:
    8
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.83
  • 拓扑面积:
    101
  • 氢给体数:
    1
  • 氢受体数:
    9

反应信息

  • 作为反应物:
    描述:
    6-O-acetyl-2-azido-2-deoxy-3,4-di-O-methyl-α,β-D-glucopyranose trichloroacetimidate 、 methyl(methyl 2,3-di-O-methyl-β-D-glucopyranosyluronate)-(1-4)-(2,3,6-tri-O-acetyl-α-D-glucopyranosyl)-(1-4)-(methyl 2,3-di-O-methyl-α-L-idopyranosyluronate)-(1-4)-2,3,6-tri-O-acetyl-α-D-glucopyranoside 在 叔丁基二甲硅基三氟甲磺酸酯 作用下, 以 乙醚二氯甲烷 为溶剂, 反应 0.67h, 生成 methyl(6-O-acetyl-2-azido-2-deoxy-3,4-di-O-methyl-α-D-glucopyranosyl)-(1-4)-(methyl 2,3-di-O-methyl-β-D-glucopyranosyluronate)-(1-4)-(2,3,6-tri-O-acetyl-α-D-glucopyranosyl)-(1-4)-(methyl 2,3,6-tri-O-methyl-α-L-idopyranosyluronate)-(1-4)-2,3,6-tri-O-acetyl-α-D-glucopyranoside
    参考文献:
    名称:
    Novel polysaccharides with antithrombotic activity comprising at least one covalent bond with biotin or a biotin derivative
    摘要:
    本发明涉及具有抗血栓活性的新型合成多糖,其至少与生物素或生物素衍生物之一形成共价键,以及利用亲和素或链球菌素的过程,使得可以中和这些多糖。
    公开号:
    US20060160768A1
点击查看最新优质反应信息

文献信息

  • ANTICOAGULANT COMPOUNDS
    申请人:Petitou Maurice
    公开号:US20100081708A1
    公开(公告)日:2010-04-01
    The present invention is concerned with anticoagulants (i.e. substances that stop blood from clotting). More specifically, the present invention is concerned with orally available antithrombic oligosaccharides.
    本发明涉及抗凝剂(即阻止血液凝结的物质)。更具体地说,本发明涉及口服可用的抗血栓寡糖
  • Polysaccharides with antithrombotic activity comprising at least a covalent bond with biotin or a biotin derivative
    申请人:——
    公开号:US20040024197A1
    公开(公告)日:2004-02-05
    The present invention relates to novel synthetic polysaccharides with antithrombotic activity exhibiting at least one covalent bond with biotin or a biotin derivative and to a process employing avidin or streptavidin which makes it possible to neutralize these polysaccharides.
    本发明涉及具有抗血栓活性的新型合成多糖,这些多糖生物素或生物素衍生物至少有一个共价键,本发明还涉及一种使用阿维菌素链霉亲和素的工艺,这种工艺可以中和这些多糖
  • POLYSACCHARIDES A ACTIVITE ANTITHROMBOTIQUE COMPRENANT AU MOINS UNE LIAISON COVALENTE AVEC LA BIOTINE OU UN DERIVE DE LA BIOTINE
    申请人:Sanofi-Aventis
    公开号:EP1322673B1
    公开(公告)日:2007-09-26
  • Novel Polysaccharides with Antithrombotic Activity Comprising at Least One Covalent Bond with Biotin or a Biotin Derivative
    申请人:Duchaussoy Philippe
    公开号:US20110144042A1
    公开(公告)日:2011-06-16
    The present invention relates to novel synthetic polysaccharides with antithrombotic activity exhibiting at least one covalent bond with biotin or a biotin derivative and to a process employing avidin or streptavidin which makes it possible to neutralize these polysaccharides.
  • US6844329B2
    申请人:——
    公开号:US6844329B2
    公开(公告)日:2005-01-18
查看更多